Exelixis, An IBD 50 Stock, Pulls A Bearish Move With Surprise Cancer Delay
I can’t summarize this article because the provided text contains only legal/disclaimer material and no news details about Exelixis or the claimed “cancer delay.” Please paste the actual article body (or key figures/paragraphs).
Sep 11, 2026 ·
Yahoo Finance


















